title: Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation.
abstract: BACKGROUND
  Traditionally organ availability in human lung transplantation has been limited by aiming to keep the graft ischemic time under 6 hours. To maximize organ supply in a country with a widely spread population, we have routinely procured organs beyond this time. Our experience outlines the clinical consequences of a prolonged allograft ischemic time.
  
  
  METHODS
  Between 1990 and 1994 we performed 106 lung or heart-lung transplantations. The average graft ischemic time was 323 +/- 93 minutes. Lung preservation included a prostacyclin infusion (40 to 80 ng/kg/min for 10 minutes) and cold modified Euro-Collins solution flush. Organs were stored and transported on ice at 6 degrees to 10 degrees C. Graft ischemic time, transplant type, age, gender, cytomegalovirus status, and anesthetic time were subject to multivariate Cox regression analysis.
  
  
  RESULTS
  Survival and graft ischemic times for heart-lung (n = 38), single lung (n = 33), and bilateral lung transplantation (n = 35) were not significantly different. Graft ischemic time was an independent predictor of survival (p < 0.01). Subgroup analysis notes the effect to be most pronounced beyond 5 hours (p = 0.02, hazard ratio 3.44, confidence interval 1.12 to 9.8).
  
  
  CONCLUSIONS
  Pulmonary allograft ischemic time beyond 5 hours does not result in acceptable outcomes although survival is reduced. Attempts should be made to minimize graft ischemic times with careful coordination of transport and personnel.
authors.affiliation: Heart and Lung Replacement Service, Alfred Hospital, Prahran, Victoria, Australia.
authors.forename: G I
authors.initials: GI
authors.lastname: Snell
authors.forename: M
authors.initials: M
authors.lastname: Rabinov
authors.forename: A
authors.initials: A
authors.lastname: Griffiths
authors.forename: T
authors.initials: T
authors.lastname: Williams
authors.forename: A
authors.initials: A
authors.lastname: Ugoni
authors.forename: R
authors.initials: R
authors.lastname: Salamonsson
authors.forename: D
authors.initials: D
authors.lastname: Esmore
mesh_terms: D000328:Adult; D016001:Confidence Intervals; D005260:Female; D006085:Graft Survival / Q000502:physiology*; D016041:Heart-Lung Transplantation / Q000502:physiology; D006801:Humans; D016040:Lung Transplantation / Q000502:physiology*; D008297:Male; D011379:Prognosis; D015427:Reperfusion Injury / Q000503:physiopathology*; D012307:Risk Factors; D016019:Survival Analysis; D014021:Tissue Preservation; D009927:Tissue and Organ Procurement